Bernie Sanders (I-Vt.), a prominent critic of high drug costs, called the announcement a "modest step forward." "Novo Nordisk's move to cut the price of Ozempic to $499 for the uninsured is a modest step forward, but let's not forget," Sanders said on social platform X, "Ozempic costs just $59 in Germany while it costs less than $5 to make
Understanding retatrutide: the triple-receptor approach Retatrutide represents something genuinely new in metabolic pharmacology
Several companies are working on new triple agonists and other combination therapies
[00:18:26] Emily Field: Research suggests that without intervention, adults roughly lose about three to 8% of their muscle mass per decade, and that rate of weight loss tends to accelerate after age 60, especially if someone is sedentary or not engaging in resistance training
That advantage holds in compounded forms as well
The benefit-risk profile at both the 9 mg and 12 mg doses appears favorable, though individual tolerability will vary as it does with all incretin-based therapies
